Skip to main content
OpenTrials
Completed

NCT Number: NCT06555861

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)

The aim of this retrospective multicentric study was to develop and evaluate a prognostic FDG PET/CT radiomics signature in early-stage non-small cell lung cancer (NSCLC) patients treated with stereotactic radiotherapy (SBRT).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Identify FDG PET/CT Parameters Predictive of Local Control Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

ICO, Nantes, Saint Herblain, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • NSCLC stage I-II treated by SBRT
  • PET/CT imaging performed within 60 days of SBRT

Exclusion criteria

  • Lack of follow-up
  • Refusal of consent

Treatment and study plan

Primary outcomes

  1. Local Recurrence

    Time frame: Time-to-Event measures up to 5 years

    accuracy

Secondary outcomes

  1. Cancer specific survival

    Time frame: Time-to-Event measures up to 5 years

    accuracy

  2. Distant metastasis free survival

    Time frame: Time-to-Event measures up to 5 years

    accuracy

  3. Recurrence free survival

    Time frame: Time-to-Event measures up to 5 years

    accuracy

  4. Overall survival

    Time frame: Time-to-Event measures up to 5 years

    accuracy

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT)

Acronym: MUMOFRAT retro

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Aug 15, 2024
Registry last updated
Aug 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.